CVS Health® (NYSE: CVS) has announced that CVS Pharmacy® locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients seeking birth control can be evaluated by a CVS pharmacist and, if eligible, receive a prescription directly from the pharmacy.
With many women in the U.S. facing challenges accessing birth control, and one in three women struggling to get prescriptions, this new service aims to bridge the gap and offer convenient, affordable access to contraception in Massachusetts.
“Hormonal birth control is a safe and effective method for preventing unplanned pregnancies, yet many women find it difficult to obtain,” said Senator Michael Moore of Millbury. “Allowing pharmacists to prescribe these medications will enhance access and align Massachusetts with 27 other states and D.C. in offering this essential service.”
Representative Christine Barber of Somerville emphasized the importance of this service for health equity, stating, “This law reflects our commitment to reproductive justice and will help ensure broader access to necessary health care.”
Representative Lindsay Sabadosa of Northampton added, “Pharmacists providing birth control will give patients more choices and greater convenience, putting control back in their hands.”
How It Works:
Patients in Massachusetts can visit any CVS Pharmacy location for a birth control consultation. They will complete a health screening form and have their blood pressure checked. The pharmacist will review the results and determine eligibility for a prescription. Available options include pills and transdermal patches. The consultation fee is $39, and payment can be made using HSA or FSA funds. Costs for the birth control itself depend on the patient’s insurance coverage. Pharmacists will also recommend follow-up care with a physician if needed.
This service follows the authorization included in the Massachusetts 2024 State Budget, signed into law in August 2023, and was supported by State Senator Michael Moore and State Representatives Christine Barber and Lindsay Sabadosa.
